About
Samet Yildirim is a biotechnology entrepreneur and KGI MBS alumnus focused on regenerative medicine, bioprocessing, and commercialization. KGI says he is Co-founder and Chief Business Officer of HexemBio and previously spent nearly a decade at Boehringer Ingelheim, including as Global Head of Technology and Innovation in the Biopharma Business Unit. He also co-founded Orbillion Bio, a Y Combinator-backed cultivated-meat startup, and serves on KGI's Amgen Bioprocessing Center Advisory Board.
Areas of interest
longevityregenerative medicinebiotechcell therapybioprocessingadvanced biomanufacturingcommercializationcultivated meatfoodtechsustainable protein